NCT05200871View on ClinicalTrials.gov

Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)

CompletedOBSERVATIONAL
Enrollment

487

Participants

Timeline

Start Date

February 5, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Focal Segmental GlomerulosclerosisImmunoglobulin A Nephropathy
Trial Locations (6)

19406

Travere Investigational Site, King of Prussia

27599

Travere Investigational Site, Chapel Hill

28002

Travere Investigational Site, Madrid

94115

Travere Investigational Site, San Francisco

07719

Travere Investigational Site, Belmar

Unknown

Travere Investigational Site, Villingen-Schwenningen

All Listed Sponsors
lead

Travere Therapeutics, Inc.

INDUSTRY